Search clinical trials for: Gastroesophageal Junction Adenocarcinoma

Total 13222 results

American College of Radiology Imaging Network
National Cancer Institute (NCI)

Completed

Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer

Prostate Cancer

United States
Abbott

Completed

Atrasentan in Treating Patients With Prostate Cancer

Prostate Cancer

United States
Millennium Pharmaceuticals, Inc.

Terminated

VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features

Carcinoma, Non-Small-Cell Lung | Adenocarcinoma, Bronchiolo-Alveolar

United States
Mauna Kea Technologies
Emissary International LLC; Cellvizio Inc.

Completed

A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers

Pancreatic Cancer | Bile Duct Cancer

United States, Germany, France
AstraZeneca
i3 Innovus

Completed

Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France (REMAIN)

Gastroesophageal Reflux Disease

France
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Unknown

Colorectal Cancer Detection by Means of Optical Fluoroscopy

Colorectal Cancer

Italy
AstraZeneca

Suspended

Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)

Kidney Neoplasms | Carcinoma, Renal Cell

United States
AstraZeneca

Completed

Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously

GERD
AstraZeneca

Completed

An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)

GERD
AstraZeneca

Completed

Chronic Posterior Laryngitis With Suspected Laryngopharyngeal Reflux

Chronic Posterior Laryngitis (CPL)
AstraZeneca
Mitsubishi Tanabe Pharma Corporation

Completed

A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population

Non-erosive Reflux Disease

Japan
National Taiwan University Hospital

Unknown

Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy

Hepatocellular Carcinoma

Taiwan
AstraZeneca

Completed

Chest Pain Pilot Study

Chest Pain | Gastroesophageal Reflux

Sweden, Germany, Denmark, Norway, Canada, Netherlands
AstraZeneca
Mitsubishi Tanabe Pharma Corporation

Completed

Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population

Non-erosive Reflux Disease

Japan
AstraZeneca

Completed

Symptom Adapted Therapy in GERD Patients (SYMPATHY)

Gastroesophageal Reflux Disease

Germany
AstraZeneca

Completed

Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease
AstraZeneca

Completed

Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and iv

Gastroesophageal Reflux Disease
Johnson & Johnson Pharmaceutical Research & Development...

Terminated

A Study of Cisapride in Patients With Symptomatic Gastro-Oesophageal Reflux Disease

Gastroesophageal Reflux
AstraZeneca

Completed

Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease | Heartburn
AstraZeneca

Completed

Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate Cancer (AZD2171IL/0003)

Advanced Prostate Adenocarcinoma

United States
Yonsei University
Severance Hospital

Unknown

Study of PIVKA-II and AFP Measurement in Surveillance Program for Early Detection of Hepatocellular Carcinoma

Hepatocellular Carcinoma

Korea, Republic of
AstraZeneca

Completed

Non-interventional Study to Evaluate the Change in Symptoms Scores and Treatment Response After 4 Weeks of Proton-Pump Inhibitors (PPI) Treatment

Gastroesophageal Reflux

Romania
Johnson & Johnson Pharmaceutical Research & Development...
Eisai Inc.

Completed

A Pharmacokinetic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Years Old, Inclusive

GERD
Taipei Veterans General Hospital, Taiwan

Unknown

Study in Asia of the Combination of TACE With Sorafenib in HCC Patients (START)

Hepatocellular Carcinoma

Taiwan
Taipei Veterans General Hospital, Taiwan

Unknown

Entecavir for Chronic Hepatitis B in Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation Therapy

Hepatocellular Carcinoma | Chronic Hepatitis B

Taiwan
University of Alabama at Birmingham
National Cancer Institute (NCI); Ionis Pharmaceuticals, Inc.

Completed

ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas

Pancreatic Cancer

United States
Universitaire Ziekenhuizen KU Leuven

Completed

Early Metabolic Response in Locally Advanced Esophageal Cancer Undergoing Induction Chemoradiotherapy

Esophageal Carcinoma (Squamous Cell Carcinoma - Adenocarcinoma)

Belgium
Japan Liver Oncology Group

Unknown

Sonazoid Enhanced Liver Cancer Trial for Early Detection

Liver Cirrhosis | Hepatitis B | Hepatocellular Carcinoma | Hepatitis C

Japan
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Completed

Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor

Sarcoma | Brain and Central Nervous System Tumors | Gastrointestinal Stromal Tumor

United States
Fukushima Medical University
Human Genome Center, Institute of Medical Science, University of Tokyo

Unknown

Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma

Hepatocellular Carcinoma

Japan
The Cleveland Clinic

Completed

Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma

Prostate Cancer | Post-Brachytherapy Bladder Outlet Obstruction

United States
AstraZeneca

Completed

Efficacy and Safety of Esomeprazole Once Daily for the Treatment of GERD in Neonatal Patients

GERD

Germany, United Kingdom, Australia
AstraZeneca

Completed

Reflux Esophagitis Phase III Study (Initial Treatment)

Reflux Esophagitis

Japan
National Taiwan University Hospital

Unknown

Symptom Assessment for GERD Patients Receiving H. Pylori Eradication

Gastroesophageal Reflux Disease

Taiwan
Cantonal Hospital of St. Gallen

Completed

Diagnostic Value of C-reactive Protein for Detection of Postoperative Inflammatory Complications After Gastroesophageal Cancer Surgery

Given Indication for Gastroesophageal Cancer Surgery

Switzerland
AstraZeneca

Completed

AZD3355 Dose-escalation Study in Healthy Males

Reflux Disease

Sweden
Iwate Medical University
Human Genome Center, Institute of Medical Science, University of Tokyo

Completed

Novel Peptide Vaccination for Patients With Advanced Renal Cell Carcinoma

Renal Cell Carcinoma
AstraZeneca

Completed

The Clinical Significance of Minimal Change in Reflux Esophagitis Based on the Gastroesophageal Reflux Disease Questionnaire (MIGHT)

Gastroesophageal Reflux Disease

Korea, Republic of
AstraZeneca

Completed

Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients (Preedom)

Gastroesophageal Reflux Disease

Korea, Republic of
AstraZeneca

Completed

Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD) (PHENIX)

Gastroesophageal Reflux Disease

Croatia
AstraZeneca

Completed

Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.

Gastroesophageal Reflux Disease

Vietnam
AstraZeneca

Completed

Structured Treatment of Gastroesophageal Reflux in a Company Health Care Setting, -Effect on Quality of Life, Symptoms and Productivity

GERD

Sweden
AstraZeneca

Completed

Gastroesophageal Reflux Disease (GERD) Segmentation: Document How Swiss General Practitioners (GPs) Allocate Their GERD Patients to the Three GERD Patient Segments

GERD

Switzerland
AstraZeneca

Completed

Drug Interaction Study Between AZD3355 and Nexium

Gastroesophageal Reflux Disease

Sweden
AstraZeneca

Completed

Study to Compare Different Formulations of AZD3355

Gastroesophageal Reflux Disease

Sweden
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of Efficacy and Safety of "On-demand" Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD)

Gastroesophageal Reflux | Heartburn
China Medical University Hospital

Unknown

Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma

Lung Adenocarcinoma

Taiwan
China Medical University Hospital

Unknown

Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma

Lung Adenocarcinoma

Taiwan
Kindai University

Completed

Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy (SILIUS)

Hepatocellular Carcinoma

Japan
National Taiwan University Hospital
National Science Council, Taiwan

Unknown

Different Genetic Features Associated With Hepatic Carcinogenesis

Hepatocellular Carcinoma

Taiwan

3

Subscribe